Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Diseases | 4 | 2024 | 385 | 1.640 |
Why?
|
Receptors, G-Protein-Coupled | 5 | 2015 | 1244 | 0.970 |
Why?
|
Antibodies, Monoclonal | 8 | 2018 | 9245 | 0.880 |
Why?
|
Pituitary Neoplasms | 4 | 2024 | 1322 | 0.780 |
Why?
|
Thyrotoxicosis | 2 | 2019 | 85 | 0.750 |
Why?
|
Adenoma | 4 | 2024 | 2155 | 0.650 |
Why?
|
Hypothyroidism | 3 | 2019 | 667 | 0.630 |
Why?
|
Endocrine System Diseases | 2 | 2018 | 250 | 0.620 |
Why?
|
Addison Disease | 1 | 2019 | 48 | 0.620 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2021 | 180 | 0.600 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2024 | 3449 | 0.570 |
Why?
|
Adrenal Cortex Hormones | 2 | 2015 | 1883 | 0.520 |
Why?
|
Melanoma | 6 | 2016 | 5702 | 0.510 |
Why?
|
Receptors, Neuropeptide | 1 | 2015 | 106 | 0.480 |
Why?
|
Adamantane | 1 | 2015 | 148 | 0.470 |
Why?
|
Prednisone | 1 | 2019 | 1566 | 0.460 |
Why?
|
Neurosecretory Systems | 1 | 2015 | 223 | 0.440 |
Why?
|
Pituitary Diseases | 1 | 2014 | 137 | 0.440 |
Why?
|
Hyperglycemia | 1 | 2022 | 1388 | 0.440 |
Why?
|
Immunomodulation | 1 | 2017 | 548 | 0.440 |
Why?
|
Dipeptides | 1 | 2015 | 386 | 0.430 |
Why?
|
Adrenal Insufficiency | 2 | 2013 | 194 | 0.430 |
Why?
|
Hydrocortisone | 1 | 2021 | 1840 | 0.410 |
Why?
|
Adrenal Gland Diseases | 1 | 2013 | 141 | 0.400 |
Why?
|
Autoimmune Diseases | 2 | 2015 | 2255 | 0.390 |
Why?
|
Reproduction | 1 | 2015 | 646 | 0.360 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2010 | 101 | 0.350 |
Why?
|
Neoplasms | 6 | 2019 | 22350 | 0.340 |
Why?
|
Mucous Membrane | 1 | 2013 | 659 | 0.340 |
Why?
|
Neuropeptides | 1 | 2015 | 950 | 0.340 |
Why?
|
Calcium Signaling | 1 | 2013 | 736 | 0.320 |
Why?
|
Diabetes Mellitus | 3 | 2024 | 5886 | 0.310 |
Why?
|
Graves Ophthalmopathy | 1 | 2010 | 135 | 0.300 |
Why?
|
Antineoplastic Agents | 3 | 2014 | 13650 | 0.260 |
Why?
|
Mutation, Missense | 1 | 2015 | 2592 | 0.260 |
Why?
|
Prolactinoma | 1 | 2024 | 114 | 0.220 |
Why?
|
Immunotherapy | 2 | 2019 | 4745 | 0.220 |
Why?
|
CHO Cells | 3 | 2015 | 1376 | 0.220 |
Why?
|
Computational Biology | 1 | 2015 | 3567 | 0.210 |
Why?
|
Cricetulus | 2 | 2015 | 810 | 0.210 |
Why?
|
Prolactin | 1 | 2024 | 627 | 0.200 |
Why?
|
Luteinizing Hormone | 2 | 2015 | 822 | 0.200 |
Why?
|
Retrospective Studies | 9 | 2024 | 81659 | 0.180 |
Why?
|
Endocrine Glands | 2 | 2018 | 101 | 0.180 |
Why?
|
Breast Neoplasms | 3 | 2024 | 21178 | 0.180 |
Why?
|
Acromegaly | 1 | 2024 | 315 | 0.180 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2021 | 64 | 0.170 |
Why?
|
Middle Aged | 15 | 2024 | 223233 | 0.170 |
Why?
|
Autoimmunity | 2 | 2018 | 1361 | 0.160 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 619 | 0.160 |
Why?
|
Tumor Burden | 1 | 2024 | 1903 | 0.150 |
Why?
|
Humans | 29 | 2024 | 767040 | 0.140 |
Why?
|
Prognosis | 3 | 2022 | 29963 | 0.130 |
Why?
|
Female | 18 | 2024 | 396660 | 0.130 |
Why?
|
Postoperative Period | 1 | 2021 | 1824 | 0.130 |
Why?
|
Skin Neoplasms | 2 | 2016 | 5859 | 0.130 |
Why?
|
Inositol Phosphates | 1 | 2015 | 175 | 0.120 |
Why?
|
Radioligand Assay | 1 | 2015 | 365 | 0.120 |
Why?
|
Receptors, Neurokinin-3 | 1 | 2015 | 59 | 0.120 |
Why?
|
Receptors, LHRH | 1 | 2015 | 158 | 0.120 |
Why?
|
Adult | 11 | 2024 | 223317 | 0.120 |
Why?
|
Remission Induction | 1 | 2021 | 2408 | 0.120 |
Why?
|
Receptor, erbB-2 | 2 | 2022 | 2599 | 0.120 |
Why?
|
PubMed | 1 | 2015 | 129 | 0.120 |
Why?
|
Craniopharyngioma | 1 | 2017 | 279 | 0.120 |
Why?
|
Arrestins | 1 | 2014 | 73 | 0.110 |
Why?
|
Receptors, Peptide | 1 | 2015 | 280 | 0.110 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2014 | 148 | 0.110 |
Why?
|
Aged | 8 | 2024 | 171319 | 0.110 |
Why?
|
Cricetinae | 2 | 2013 | 2415 | 0.100 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 616 | 0.100 |
Why?
|
Cohort Studies | 3 | 2023 | 41718 | 0.100 |
Why?
|
Rhabdomyolysis | 1 | 2013 | 150 | 0.100 |
Why?
|
Male | 15 | 2024 | 364203 | 0.100 |
Why?
|
Infertility, Male | 1 | 2015 | 396 | 0.100 |
Why?
|
Iodine Radioisotopes | 1 | 2015 | 1029 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15424 | 0.100 |
Why?
|
Calcium | 2 | 2015 | 5792 | 0.090 |
Why?
|
Treatment Outcome | 4 | 2024 | 65295 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 615 | 0.090 |
Why?
|
HEK293 Cells | 3 | 2014 | 4280 | 0.090 |
Why?
|
Neurosurgical Procedures | 1 | 2021 | 2075 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1804 | 0.080 |
Why?
|
Circadian Rhythm | 1 | 2021 | 2591 | 0.080 |
Why?
|
Computer-Assisted Instruction | 1 | 2012 | 368 | 0.080 |
Why?
|
Phenotype | 3 | 2024 | 16718 | 0.080 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 2047 | 0.080 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39317 | 0.080 |
Why?
|
Recurrence | 1 | 2021 | 8504 | 0.070 |
Why?
|
Medical Staff, Hospital | 1 | 2012 | 602 | 0.070 |
Why?
|
Protein Transport | 1 | 2013 | 1944 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14766 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2824 | 0.060 |
Why?
|
Drug Monitoring | 1 | 2012 | 963 | 0.060 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2011 | 1149 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12823 | 0.060 |
Why?
|
Heterozygote | 1 | 2011 | 2794 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6513 | 0.060 |
Why?
|
Software | 2 | 2015 | 4472 | 0.050 |
Why?
|
Incidence | 2 | 2019 | 21526 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2015 | 14476 | 0.050 |
Why?
|
Animals | 6 | 2015 | 168965 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5693 | 0.050 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 17097 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11872 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9532 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7435 | 0.040 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2024 | 475 | 0.040 |
Why?
|
Inpatients | 1 | 2012 | 2563 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2012 | 3488 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2024 | 643 | 0.040 |
Why?
|
Neurons | 2 | 2015 | 9517 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2012 | 4306 | 0.030 |
Why?
|
Chromogranins | 1 | 2017 | 160 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2019 | 59548 | 0.030 |
Why?
|
Clinical Competence | 1 | 2012 | 4859 | 0.030 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2016 | 200 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 16036 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 194 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 36582 | 0.030 |
Why?
|
Buserelin | 1 | 2014 | 16 | 0.030 |
Why?
|
Thiazoles | 1 | 2022 | 1530 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15925 | 0.030 |
Why?
|
Endoscopy | 1 | 2024 | 1854 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2252 | 0.030 |
Why?
|
Mice | 3 | 2015 | 81912 | 0.030 |
Why?
|
Inflammation | 1 | 2013 | 10869 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1211 | 0.030 |
Why?
|
Internship and Residency | 1 | 2012 | 5947 | 0.020 |
Why?
|
Oncogenes | 1 | 2017 | 1232 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3108 | 0.020 |
Why?
|
United States | 1 | 2019 | 72971 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2017 | 8628 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20741 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2721 | 0.020 |
Why?
|
Blood Glucose | 1 | 2024 | 6421 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2016 | 2428 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 1969 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 4892 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3440 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3667 | 0.010 |
Why?
|
Program Evaluation | 1 | 2012 | 2505 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11063 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10393 | 0.010 |
Why?
|
Peptides | 1 | 2012 | 4348 | 0.010 |
Why?
|
Signal Transduction | 2 | 2014 | 23621 | 0.010 |
Why?
|
Boston | 1 | 2012 | 9360 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2012 | 3266 | 0.010 |
Why?
|
Communication | 1 | 2012 | 3904 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 59980 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2012 | 4054 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 13035 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9464 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22361 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18063 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 30211 | 0.010 |
Why?
|
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(38)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_